AAAAAA

   
Results: 1-19 |
Results: 19
THE NATURAL-HISTORY OF CARRIAGE OF VRE USING PCR DETECTION OF VAN-A, VAN-B, AND VAN-C-1 DIRECTLY FROM STOOL SAMPLES RECTAL SWABS - WHAT WE DONT KNOW CANT HURT US, CAN IT
Authors: WRIGHT J DEDIER H ZHAO J KRAJDEN M CAMPBELL I WEINSTEIN M BRUNTON J CONLY J
Citation: J. Wright et al., THE NATURAL-HISTORY OF CARRIAGE OF VRE USING PCR DETECTION OF VAN-A, VAN-B, AND VAN-C-1 DIRECTLY FROM STOOL SAMPLES RECTAL SWABS - WHAT WE DONT KNOW CANT HURT US, CAN IT, Infection control and hospital epidemiology, 19(9), 1998, pp. 74-74
MU-OPIOID PEPTIDES INHIBIT THALAMIC NEURONS
Authors: BRUNTON J CHARPAK S
Citation: J. Brunton et S. Charpak, MU-OPIOID PEPTIDES INHIBIT THALAMIC NEURONS, The Journal of neuroscience, 18(5), 1998, pp. 1671-1678
APPLICATION OF MULTIPLEX PCR FOR DETECTION OF NON-O157 VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI IN BLOODY STOOLS - IDENTIFICATION OF SEROGROUPS O26 AND O111
Authors: LOUIE M READ S SIMOR AE HOLLAND J LOUIE L ZIEBELL K BRUNTON J HII J
Citation: M. Louie et al., APPLICATION OF MULTIPLEX PCR FOR DETECTION OF NON-O157 VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI IN BLOODY STOOLS - IDENTIFICATION OF SEROGROUPS O26 AND O111, Journal of clinical microbiology (Print), 36(11), 1998, pp. 3375-3377
EFFECT OF BICUCULLINE ON THALAMIC ACTIVITY - A DIRECT BLOCKADE OF I-AHP IN RETICULARIS NEURONS
Authors: DEBARBIEUX F BRUNTON J CHARPAK S
Citation: F. Debarbieux et al., EFFECT OF BICUCULLINE ON THALAMIC ACTIVITY - A DIRECT BLOCKADE OF I-AHP IN RETICULARIS NEURONS, Journal of neurophysiology, 79(6), 1998, pp. 2911-2918
HETEROGENEITY OF CELL FIRING PROPERTIES AND OPIOID SENSITIVITY IN THETHALAMIC RETICULAR NUCLEUS
Authors: BRUNTON J CHARPAK S
Citation: J. Brunton et S. Charpak, HETEROGENEITY OF CELL FIRING PROPERTIES AND OPIOID SENSITIVITY IN THETHALAMIC RETICULAR NUCLEUS, Neuroscience, 78(2), 1997, pp. 303-307
MURINE ANTIBODY-RESPONSES TO THE VEROTOXIN-1-B SUBUNIT - DEMONSTRATION OF MAJOR HISTOCOMPATIBILITY COMPLEX DEPENDENCE AND AN IMMUNODOMINANTEPITOPE INVOLVING PHENYLALANINE-30
Authors: BAST DJ SANDHU J HOZUMI N BARBER B BRUNTON J
Citation: Dj. Bast et al., MURINE ANTIBODY-RESPONSES TO THE VEROTOXIN-1-B SUBUNIT - DEMONSTRATION OF MAJOR HISTOCOMPATIBILITY COMPLEX DEPENDENCE AND AN IMMUNODOMINANTEPITOPE INVOLVING PHENYLALANINE-30, Infection and immunity, 65(7), 1997, pp. 2978-2982
INVESTIGATION OF A MULTIYEAR MULTIPLE CRITICAL CARE UNIT OUTBREAK DUETO RELATIVELY DRUG-SENSITIVE ACINETOBACTER-BAUMANNII - RISK-FACTORS AND ATTRIBUTABLE MORTALITY
Authors: KAUL R BURT JA CORK L DEDIER H GARCIA M KENNEDY C BRUNTON J KRAJDEN M CONLY J
Citation: R. Kaul et al., INVESTIGATION OF A MULTIYEAR MULTIPLE CRITICAL CARE UNIT OUTBREAK DUETO RELATIVELY DRUG-SENSITIVE ACINETOBACTER-BAUMANNII - RISK-FACTORS AND ATTRIBUTABLE MORTALITY, The Journal of infectious diseases, 174(6), 1996, pp. 1279-1287
A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ADJUNCTIVE CORTICOSTEROIDS IN THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA COMPLICATING THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
Authors: WALMSLEY S LEVINTON C BRUNTON J MURADALI D RAPPAPORT D BAST M SPENCE D SALIT I
Citation: S. Walmsley et al., A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ADJUNCTIVE CORTICOSTEROIDS IN THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA COMPLICATING THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, Journal of acquired immune deficiency syndromes and human retrovirology, 8(4), 1995, pp. 348-357
MULTIORGAN DONOR TRANSMISSION OF HEPATITIS-C VIRUS TO 5 SOLID-ORGAN TRANSPLANT RECIPIENTS AND LACK OF TRANSMISSION TO CORNEAL TRANSPLANT RECIPIENTS
Authors: KRAJDEN M BISHAI F QUAN C MAHONY J BRUNTON J ROOTMAN D ZHOA J LAU W SNELL G MAURER J KESTEN S COLBY D
Citation: M. Krajden et al., MULTIORGAN DONOR TRANSMISSION OF HEPATITIS-C VIRUS TO 5 SOLID-ORGAN TRANSPLANT RECIPIENTS AND LACK OF TRANSMISSION TO CORNEAL TRANSPLANT RECIPIENTS, Clinical and diagnostic virology, 3(2), 1995, pp. 113-121
SEQUENCE HETEROGENEITY OF THE EAE GENE AND DETECTION OF VEROTOXIN-PRODUCING ESCHERICHIA-COLI USING SEROTYPE-SPECIFIC PRIMERS
Authors: LOUIE M DEAZAVEDO J CLARKE R BORCZYK A LIOR H RICHTER M BRUNTON J
Citation: M. Louie et al., SEQUENCE HETEROGENEITY OF THE EAE GENE AND DETECTION OF VEROTOXIN-PRODUCING ESCHERICHIA-COLI USING SEROTYPE-SPECIFIC PRIMERS, Epidemiology and infection, 112(3), 1994, pp. 449-461
NORTH-AMERICAN (UNITED-STATES AND CANADA) COMPARATIVE SUSCEPTIBILITY OF 2 FLUOROQUINOLONES - OFLOXACIN AND CIPROFLOXACIN - A 53-MEDICAL-CENTER SAMPLE OF SPECTRA OF ACTIVITY
Authors: JONES RN HOBAN DJ ALDRIDGE KA ARRINGTON KL BERTHOLD G BRECHER S CLEARY T COYLE M DAVIS J GARAGUSI V GOODMAN NL GORZYNSKI E HANFF P HANNA B ISENBERG HD MCGOWAN J MARTIN WJ MOODY J MURRAY PR RELLER LB RINALDI MG ROSATI LA RYPKA E SAHM D SLIFKIN M SEWELL D SPIEGEL C STECKELBERG JM STEELEMOORE L STEIN G STRATTON C STROZEWSKI K WEINSTEIN M WELCH B WHITE RL WINN W ALFA M NUNS G BLONDEAU J BOURGAULT AM BRUNTON J CLARKE AM FORWARD K GREGSON DB HORSMAN GB JESSAMINE P KIBSEY P KUHN M LAVERDIERE M LOW DE NOBLE MA RENNIE R SMITH JA
Citation: Rn. Jones et al., NORTH-AMERICAN (UNITED-STATES AND CANADA) COMPARATIVE SUSCEPTIBILITY OF 2 FLUOROQUINOLONES - OFLOXACIN AND CIPROFLOXACIN - A 53-MEDICAL-CENTER SAMPLE OF SPECTRA OF ACTIVITY, Diagnostic microbiology and infectious disease, 18(1), 1994, pp. 49-56
ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR DETECTION OF IMMUNOGLOBULIN-G ANTIBODIES TO ESCHERICHIA-COLI VERO CYTOTOXIN-1
Authors: KARMALI MA PETRIC M WINKLER M BIELASZEWSKA M BRUNTON J VANDEKAR N MOROOKA T NAIR GB RICHARDSON SE ARBUS GS
Citation: Ma. Karmali et al., ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR DETECTION OF IMMUNOGLOBULIN-G ANTIBODIES TO ESCHERICHIA-COLI VERO CYTOTOXIN-1, Journal of clinical microbiology, 32(6), 1994, pp. 1457-1463
DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITIES OF CANADIAN ISOLATES OF HAEMOPHILUS-INFLUENZAE AND CHARACTERIZATION OF THEIR BETA-LACTAMASES
Authors: SCRIVER SR WALMSLEY SL KAU CL HOBAN DJ BRUNTON J MCGEER A MOORE TC WITWICKI E ABBOTT LP ALFA M ANAND D ANDERSON J BERGERON MG BLONDEAU J CLARKE AM DIAZMITOMA F FORWARD K GREGSON D HORSMEN GB JESSAMINE P KIBSEY P KUHN M LAVADIERE M MARTIN T MCDONALD JC MCNAUGHTON RD SMITH J ZOUTMAN D LOW DE
Citation: Sr. Scriver et al., DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITIES OF CANADIAN ISOLATES OF HAEMOPHILUS-INFLUENZAE AND CHARACTERIZATION OF THEIR BETA-LACTAMASES, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1678-1680
ALTERATION OF THE GLYCOLIPID BINDING-SPECIFICITY OF THE PIG EDEMA TOXIN FROM GLOBOTETRAOSYL TO GLOBOTRIASOYL CERAMIDE ALTERS INVIVO TISSUE TARGETING AND RESULTS IN A VEROTOXIN-1 LIKE DISEASE IN PIGS
Authors: BOYD B TYRRELL G MALONEY M GYLES C BRUNTON J LINGWOOD C
Citation: B. Boyd et al., ALTERATION OF THE GLYCOLIPID BINDING-SPECIFICITY OF THE PIG EDEMA TOXIN FROM GLOBOTETRAOSYL TO GLOBOTRIASOYL CERAMIDE ALTERS INVIVO TISSUE TARGETING AND RESULTS IN A VEROTOXIN-1 LIKE DISEASE IN PIGS, The Journal of experimental medicine, 177(6), 1993, pp. 1745-1753
MULTIPLE DETERMINANTS OF VEROTOXIN-PRODUCING ESCHERICHIA-COLI O157-H7ATTACHMENT-EFFACEMENT
Authors: DYTOC M SONI R COCKERILL F DEAZAVEDO J LOUIE M BRUNTON J SHERMAN P
Citation: M. Dytoc et al., MULTIPLE DETERMINANTS OF VEROTOXIN-PRODUCING ESCHERICHIA-COLI O157-H7ATTACHMENT-EFFACEMENT, Infection and immunity, 61(8), 1993, pp. 3382-3391
EXPRESSION AND CHARACTERIZATION OF THE EAEA GENE-PRODUCT OF ESCHERICHIA-COLI SEROTYPE O157-H7
Authors: LOUIE M DEAZAVEDO JCS HANDELSMAN MYC CLARK CG ALLY B DYTOC M SHERMAN P BRUNTON J
Citation: M. Louie et al., EXPRESSION AND CHARACTERIZATION OF THE EAEA GENE-PRODUCT OF ESCHERICHIA-COLI SEROTYPE O157-H7, Infection and immunity, 61(10), 1993, pp. 4085-4092
USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .1.
Authors: POWERS TE SUNDLOF S RITTER L GUEST G POWERS T JENKINS W BRUNTON J ZELLER M MACOMBER LE CLARK J LOEW F REID J MCCARTHY J JOHNSON G BRUMBAUGH G JOHNSON DE
Citation: Te. Powers et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .1., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1626-1631
USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .3.
Authors: GLOYD J",KEELING,MACOMBER,"LEIN D BANVILLE A",CRAWFORD,"BRUMBAUGH G",STRIBLING,HOLT,"WILSON J HUBBARD W BRUNTON J GINGERICH D JOHNSON G LUTHER L WEISSINGER J COPPOC G RITTER L
Citation: D. Gloyd J",keeling,macomber,"lein et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .3., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1684-1692
USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .4.
Authors: BRUMBAUGH G BOOTHE D BROWN SA GINGERICH DA GLOYD J HILL A POWERS T WILSON J SUNDLOF SF BRUNTON J COPPOC G WILLIAMS H MACOMBER LE TERRY M
Citation: G. Brumbaugh et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .4., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1713-1717
Risultati: 1-19 |